Search research articles
Contact Us
Filters
Showing results (81-90 of 95) with videos related to
Page
of 10
Sort By:
Circulation Journal : Official Journal of the Japanese Circulation Society
|
April 3, 2024
Chronic Effects of Adaptive Servo-Ventilation Therapy on Mortality and the Urgent Rehospitalization Rate in Patients Experiencing Recurrent Admissions for Heart Failure - A Multicenter Prospective Observational Study (SAVIOR-L)
Yoshihiro Fukumoto, Takeshi Tada, Hideaki Suzuki, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society
|
November 9, 2020
Monotherapy With Prasugrel After Dual-Antiplatelet Therapy for Japanese Percutaneous Coronary Intervention Patients With High Bleeding Risk - A Prospective Cohort Study (PENDULUM mono Study)
Masato Nakamura, Yoshihiro Morino, Tsunekazu Kakuta, et al.
Journal of the American College of Cardiology
|
October 25, 2023
Clopidogrel vs Aspirin Monotherapy Beyond 1 Year After Percutaneous Coronary Intervention
Hirotoshi Watanabe, Takeshi Morimoto, Masahiro Natsuaki, et al.
The American Journal of Cardiology
|
September 26, 2025
Optimal Intravascular Ultrasound-Guided Percutaneous Coronary Intervention in Patients With Left Main Coronary Artery Disease: The OPTIVUS-Complex PCI Study LMCA Cohort
Ryusuke Nishikawa, Hiroki Shiomi, Ko Yamamoto, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society
|
May 17, 2023
Dual Antiplatelet Therapy Duration After Multivessel Optimal Intravascular Ultrasound-Guided Percutaneous Coronary Intervention
Ko Yamamoto, Hiroki Shiomi, Takeshi Morimoto, et al.
JACC. Asia
|
August 24, 2023
Single-Session Versus Staged Multivessel Optimal IVUS-Guided PCI in Patients With CCS or NSTE-ACS
Ko Yamamoto, Hiroki Shiomi, Takeshi Morimoto, et al.
JACC. Asia
|
May 14, 2023
Optimal Intravascular Ultrasound-Guided Percutaneous Coronary Intervention in Patients With Multivessel Disease
Ko Yamamoto, Hiroki Shiomi, Takeshi Morimoto, et al.
JAMA
|
June 26, 2019
Effect of 1-Month Dual Antiplatelet Therapy Followed by Clopidogrel vs 12-Month Dual Antiplatelet Therapy on Cardiovascular and Bleeding Events in Patients Receiving PCI: The STOPDAPT-2 Randomized Clinical Trial
Hirotoshi Watanabe, Takenori Domei, Takeshi Morimoto, et al.
Circulation. Cardiovascular Interventions
|
August 1, 2022
Clopidogrel Monotherapy After 1-Month Dual Antiplatelet Therapy in Percutaneous Coronary Intervention: From the STOPDAPT-2 Total Cohort
Yuki Obayashi, Hirotoshi Watanabe, Takeshi Morimoto, et al.
Cardiovascular Intervention and Therapeutics
|
February 23, 2020
Details on the effect of very short dual antiplatelet therapy after drug-eluting stent implantation in patients with high bleeding risk: insight from the STOPDAPT-2 trial
Hirotoshi Watanabe, Takenori Domei, Takeshi Morimoto, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 95) with videos related to
Sort By:
Page
of 10
Circulation Journal : Official Journal of the Japanese Circulation Society
|
April 3, 2024
Chronic Effects of Adaptive Servo-Ventilation Therapy on Mortality and the Urgent Rehospitalization Rate in Patients Experiencing Recurrent Admissions for Heart Failure - A Multicenter Prospective Observational Study (SAVIOR-L)
Yoshihiro Fukumoto, Takeshi Tada, Hideaki Suzuki, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society
|
November 9, 2020
Monotherapy With Prasugrel After Dual-Antiplatelet Therapy for Japanese Percutaneous Coronary Intervention Patients With High Bleeding Risk - A Prospective Cohort Study (PENDULUM mono Study)
Masato Nakamura, Yoshihiro Morino, Tsunekazu Kakuta, et al.
Journal of the American College of Cardiology
|
October 25, 2023
Clopidogrel vs Aspirin Monotherapy Beyond 1 Year After Percutaneous Coronary Intervention
Hirotoshi Watanabe, Takeshi Morimoto, Masahiro Natsuaki, et al.
The American Journal of Cardiology
|
September 26, 2025
Optimal Intravascular Ultrasound-Guided Percutaneous Coronary Intervention in Patients With Left Main Coronary Artery Disease: The OPTIVUS-Complex PCI Study LMCA Cohort
Ryusuke Nishikawa, Hiroki Shiomi, Ko Yamamoto, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society
|
May 17, 2023
Dual Antiplatelet Therapy Duration After Multivessel Optimal Intravascular Ultrasound-Guided Percutaneous Coronary Intervention
Ko Yamamoto, Hiroki Shiomi, Takeshi Morimoto, et al.
JACC. Asia
|
August 24, 2023
Single-Session Versus Staged Multivessel Optimal IVUS-Guided PCI in Patients With CCS or NSTE-ACS
Ko Yamamoto, Hiroki Shiomi, Takeshi Morimoto, et al.
JACC. Asia
|
May 14, 2023
Optimal Intravascular Ultrasound-Guided Percutaneous Coronary Intervention in Patients With Multivessel Disease
Ko Yamamoto, Hiroki Shiomi, Takeshi Morimoto, et al.
JAMA
|
June 26, 2019
Effect of 1-Month Dual Antiplatelet Therapy Followed by Clopidogrel vs 12-Month Dual Antiplatelet Therapy on Cardiovascular and Bleeding Events in Patients Receiving PCI: The STOPDAPT-2 Randomized Clinical Trial
Hirotoshi Watanabe, Takenori Domei, Takeshi Morimoto, et al.
Circulation. Cardiovascular Interventions
|
August 1, 2022
Clopidogrel Monotherapy After 1-Month Dual Antiplatelet Therapy in Percutaneous Coronary Intervention: From the STOPDAPT-2 Total Cohort
Yuki Obayashi, Hirotoshi Watanabe, Takeshi Morimoto, et al.
Cardiovascular Intervention and Therapeutics
|
February 23, 2020
Details on the effect of very short dual antiplatelet therapy after drug-eluting stent implantation in patients with high bleeding risk: insight from the STOPDAPT-2 trial
Hirotoshi Watanabe, Takenori Domei, Takeshi Morimoto, et al.
Page
of 10